NEW YORK (GenomeWeb) – NxGen MDx said today its genetic screening and noninvasive prenatal testing will be available to Aetna's members as an in-network benefit, starting Feb. 15. 

The decision by Aetna follows a review of NxGen's products' features, such as full-gene sequencing. The health plan is the third-largest in the US with more than 46 million members. It will cover NxGen MDx's testing at a national level. 

NxGen MDx offers testing for up to 120 various genetic disorders. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.